Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 205 to 210 of 210 entries
Sorted by: Best Match Show Resources per page
Formation of Cyclobutane Pyrimidine Dimers after UVA Exposure (Dark-CPDs) Is Inhibited by an Hydrophilic Extract of .

Antioxidants (Basel, Switzerland)

Portillo-Esnaola M, Rodríguez-Luna A, Nicolás-Morala J, Gallego-Rentero M, Villalba M, Juarranz Á, González S.
PMID: 34943064
Antioxidants (Basel). 2021 Dec 07;10(12). doi: 10.3390/antiox10121961.

Exposure to sun and especially to ultraviolet radiation (UVR) exerts well known detrimental effects on skin which are implicated in malignancy. UVR induces production of cyclobutane pyrimidine dimers (CPDs), immediately during exposure and even hours after the exposure, these...

Cite
Portillo-Esnaola M, Rodríguez-Luna A, Nicolás-Morala J, et al. Formation of Cyclobutane Pyrimidine Dimers after UVA Exposure (Dark-CPDs) Is Inhibited by an Hydrophilic Extract of . Antioxidants (Basel). 2021;10(12)doi: 10.3390/antiox10121961.
Portillo-Esnaola, M., Rodríguez-Luna, A., Nicolás-Morala, J., Gallego-Rentero, M., Villalba, M., Juarranz, �. �., & González, S. (2021). Formation of Cyclobutane Pyrimidine Dimers after UVA Exposure (Dark-CPDs) Is Inhibited by an Hydrophilic Extract of . Antioxidants (Basel, Switzerland), 10(12), . https://doi.org/10.3390/antiox10121961
Portillo-Esnaola, Mikel, et al. "Formation of Cyclobutane Pyrimidine Dimers after UVA Exposure (Dark-CPDs) Is Inhibited by an Hydrophilic Extract of ." Antioxidants (Basel, Switzerland) vol. 10,12 (2021). doi: https://doi.org/10.3390/antiox10121961
Portillo-Esnaola M, Rodríguez-Luna A, Nicolás-Morala J, Gallego-Rentero M, Villalba M, Juarranz Á, González S. Formation of Cyclobutane Pyrimidine Dimers after UVA Exposure (Dark-CPDs) Is Inhibited by an Hydrophilic Extract of . Antioxidants (Basel). 2021 Dec 07;10(12). doi: 10.3390/antiox10121961. PMID: 34943064; PMCID: PMC8750109.
Copy Download .nbib Format: NLM
Structure-Based Design of an RNase Chimera for Antimicrobial Therapy.

International journal of molecular sciences

Prats-Ejarque G, Lorente H, Villalba C, Anguita R, Lu L, Vázquez-Monteagudo S, Fernández-Millán P, Boix E.
PMID: 35008522
Int J Mol Sci. 2021 Dec 22;23(1). doi: 10.3390/ijms23010095.

Bacterial resistance to antibiotics urges the development of alternative therapies. Based on the structure-function of antimicrobial members of the RNase A superfamily, we have developed a hybrid enzyme. Within this family, RNase 1 exhibits the highest catalytic activity and...

Cite
Prats-Ejarque G, Lorente H, Villalba C, et al. Structure-Based Design of an RNase Chimera for Antimicrobial Therapy. Int J Mol Sci. 2021;23(1)doi: 10.3390/ijms23010095.
Prats-Ejarque, G., Lorente, H., Villalba, C., Anguita, R., Lu, L., Vázquez-Monteagudo, S., Fernández-Millán, P., & Boix, E. (2021). Structure-Based Design of an RNase Chimera for Antimicrobial Therapy. International journal of molecular sciences, 23(1), . https://doi.org/10.3390/ijms23010095
Prats-Ejarque, Guillem, et al. "Structure-Based Design of an RNase Chimera for Antimicrobial Therapy." International journal of molecular sciences vol. 23,1 (2021). doi: https://doi.org/10.3390/ijms23010095
Prats-Ejarque G, Lorente H, Villalba C, Anguita R, Lu L, Vázquez-Monteagudo S, Fernández-Millán P, Boix E. Structure-Based Design of an RNase Chimera for Antimicrobial Therapy. Int J Mol Sci. 2021 Dec 22;23(1). doi: 10.3390/ijms23010095. PMID: 35008522; PMCID: PMC8745102.
Copy Download .nbib Format: NLM
Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study.

Journal of Alzheimer's disease : JAD

Ramos C, Villalba C, García J, Lanata S, López H, Aguillón D, Cordano C, Madrigal L, Aguirre-Acevedo DC, Lopera F.
PMID: 34924385
J Alzheimers Dis. 2021 Dec 17; doi: 10.3233/JAD-215169. Epub 2021 Dec 17.

BACKGROUND: Cigarette smoking is a known risk factor for Alzheimer's disease (AD). However, the association between neurodegeneration and other substances has not been fully determined. It is of vital importance to evaluate this relationship in populations at high risk...

Cite
Ramos C, Villalba C, García J, et al. Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study. J Alzheimers Dis. 2021;doi: 10.3233/JAD-215169.
Ramos, C., Villalba, C., García, J., Lanata, S., López, H., Aguillón, D., Cordano, C., Madrigal, L., Aguirre-Acevedo, D. C., & Lopera, F. (2021). Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study. Journal of Alzheimer's disease : JAD, . https://doi.org/10.3233/JAD-215169
Ramos, Claudia, et al. "Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study." Journal of Alzheimer's disease : JAD vol. (2021). doi: https://doi.org/10.3233/JAD-215169
Ramos C, Villalba C, García J, Lanata S, López H, Aguillón D, Cordano C, Madrigal L, Aguirre-Acevedo DC, Lopera F. Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study. J Alzheimers Dis. 2021 Dec 17; doi: 10.3233/JAD-215169. Epub 2021 Dec 17. PMID: 34924385.
Copy Download .nbib Format: NLM
Cloud architecture for electronic health record systems interoperability.

Technology and health care : official journal of the European Society for Engineering and Medicine

Gómez D, Romero J, López P, Vázquez J, Cappo C, Pinto D, Villalba C.
PMID: 34511519
Technol Health Care. 2021 Sep 09; doi: 10.3233/THC-212806. Epub 2021 Sep 09.

BACKGROUND: Current Electronic Health Record (EHR) systems are built using different data representation and information models, which makes difficult achieving information exchange.OBJECTIVE: Our aim was to propose a scalable architecture that allows the integration of information from different EHR...

Cite
Gómez D, Romero J, López P, et al. Cloud architecture for electronic health record systems interoperability. Technol Health Care. 2021;doi: 10.3233/THC-212806.
Gómez, D., Romero, J., López, P., Vázquez, J., Cappo, C., Pinto, D., & Villalba, C. (2021). Cloud architecture for electronic health record systems interoperability. Technology and health care : official journal of the European Society for Engineering and Medicine, . https://doi.org/10.3233/THC-212806
Gómez, Derlis, et al. "Cloud architecture for electronic health record systems interoperability." Technology and health care : official journal of the European Society for Engineering and Medicine vol. (2021). doi: https://doi.org/10.3233/THC-212806
Gómez D, Romero J, López P, Vázquez J, Cappo C, Pinto D, Villalba C. Cloud architecture for electronic health record systems interoperability. Technol Health Care. 2021 Sep 09; doi: 10.3233/THC-212806. Epub 2021 Sep 09. PMID: 34511519.
Copy Download .nbib Format: NLM
Correspondence on: 'EULAR definition of difficult-to-treat rheumatoid arthritis'.

Annals of the rheumatic diseases

Novella-Navarro M, Plasencia-Rodríguez C, Tornero C, Navarro-Compán V, Cabrera-Alarcón JL, Peiteado D, Nuño L, Monjo I, Franco-Gómez K, Villalba A, Balsa A.
PMID: 33277240
Ann Rheum Dis. 2020 Dec 04; doi: 10.1136/annrheumdis-2020-219500. Epub 2020 Dec 04.

No abstract available.

Cite
Novella-Navarro M, Plasencia-Rodríguez C, Tornero C, et al. Correspondence on: 'EULAR definition of difficult-to-treat rheumatoid arthritis'. Ann Rheum Dis. 2020;doi: 10.1136/annrheumdis-2020-219500.
Novella-Navarro, M., Plasencia-Rodríguez, C., Tornero, C., Navarro-Compán, V., Cabrera-Alarcón, J. L., Peiteado, D., Nuño, L., Monjo, I., Franco-Gómez, K., Villalba, A., & Balsa, A. (2020). Correspondence on: 'EULAR definition of difficult-to-treat rheumatoid arthritis'. Annals of the rheumatic diseases, . https://doi.org/10.1136/annrheumdis-2020-219500
Novella-Navarro, Marta, et al. "Correspondence on: 'EULAR definition of difficult-to-treat rheumatoid arthritis'." Annals of the rheumatic diseases vol. (2020). doi: https://doi.org/10.1136/annrheumdis-2020-219500
Novella-Navarro M, Plasencia-Rodríguez C, Tornero C, Navarro-Compán V, Cabrera-Alarcón JL, Peiteado D, Nuño L, Monjo I, Franco-Gómez K, Villalba A, Balsa A. Correspondence on: 'EULAR definition of difficult-to-treat rheumatoid arthritis'. Ann Rheum Dis. 2020 Dec 04; doi: 10.1136/annrheumdis-2020-219500. Epub 2020 Dec 04. PMID: 33277240.
Copy Download .nbib Format: NLM
Recruitment location influences bias and uncertainty in SARS-CoV-2 seroprevalence estimates.

medRxiv : the preprint server for health sciences

Brown TS, de Salazar Munoz PM, Bhatia A, Bunda B, Williams EK, Bor D, Miller JS, Mohareb AM, Thierauf J, Yang W, Villalba J, Naranbai V, Beltran WG, Miller TE, Kress D, Stelljes K, Johnson K, Larremore DB, Lennerz J, Iafrate AJ, Balsari S, Buckee CO, Grad YH.
PMID: 33564784
medRxiv. 2021 Oct 05; doi: 10.1101/2021.02.03.21251011.

The initial phase of the COVID-19 pandemic in the US was marked by limited diagnostic testing, resulting in the need for seroprevalence studies to estimate cumulative incidence and define epidemic dynamics. In lieu of systematic representational surveillance, venue-based sampling...

Cite
Brown TS, de Salazar Munoz PM, Bhatia A, et al. Recruitment location influences bias and uncertainty in SARS-CoV-2 seroprevalence estimates. medRxiv. 2021;doi: 10.1101/2021.02.03.21251011.
Brown, T. S., de Salazar Munoz, P. M., Bhatia, A., Bunda, B., Williams, E. K., Bor, D., Miller, J. S., Mohareb, A. M., Thierauf, J., Yang, W., Villalba, J., Naranbai, V., Beltran, W. G., Miller, T. E., Kress, D., Stelljes, K., Johnson, K., Larremore, D. B., Lennerz, J., Iafrate, A. J., Balsari, S., Buckee, C. O., & Grad, Y. H. (2021). Recruitment location influences bias and uncertainty in SARS-CoV-2 seroprevalence estimates. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.02.03.21251011
Brown, Tyler S, et al. "Recruitment location influences bias and uncertainty in SARS-CoV-2 seroprevalence estimates." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.02.03.21251011
Brown TS, de Salazar Munoz PM, Bhatia A, Bunda B, Williams EK, Bor D, Miller JS, Mohareb AM, Thierauf J, Yang W, Villalba J, Naranbai V, Beltran WG, Miller TE, Kress D, Stelljes K, Johnson K, Larremore DB, Lennerz J, Iafrate AJ, Balsari S, Buckee CO, Grad YH. Recruitment location influences bias and uncertainty in SARS-CoV-2 seroprevalence estimates. medRxiv. 2021 Oct 05; doi: 10.1101/2021.02.03.21251011. PMID: 33564784; PMCID: PMC7872379.
Copy Download .nbib Format: NLM
Showing 205 to 210 of 210 entries